Published in J Neurol Neurosurg Psychiatry on August 14, 2010
Neuralgic amyotrophy and hepatitis E virus infection. Neurology (2014) 1.15
Hallucinations, sensory neuropathy, and peripheral visual deficits in a young woman infected with Bartonella koehlerae. J Clin Microbiol (2011) 0.95
Parsonage-Turner syndrome following post-exposure prophylaxis. BMC Musculoskelet Disord (2014) 0.75
Brachial Plexus Neuritis Associated With Streptococcus agalactiae Infection: A Case Report. Ann Rehabil Med (2014) 0.75
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol (2008) 6.06
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol (2012) 4.70
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis (2010) 3.37
A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol (2007) 2.73
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain (2008) 2.60
Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol (2008) 2.47
Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann Neurol (2009) 2.26
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J Clin Invest (2004) 2.25
Residual fatigue in Guillain-Barre syndrome is related to axonal loss. Neurology (2013) 2.01
The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol (2004) 1.96
Operative treatment of anterior thoracic spinal cord herniation: three new cases and an individual patient data meta-analysis of 126 case reports. Neurosurgery (2009) 1.79
Peripheral nerve involvement in spinocerebellar ataxias. Arch Neurol (2004) 1.72
Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol (2009) 1.67
Predictors of poor neurologic outcome in patients after cardiac arrest treated with hypothermia: a retrospective study. Resuscitation (2011) 1.62
Guillain-Barré syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatry (2011) 1.62
Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun (2007) 1.60
Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2013) 1.57
IVIG treatment and prognosis in Guillain-Barré syndrome. J Clin Immunol (2010) 1.46
Muscles alive: ultrasound detects fibrillations. Clin Neurophysiol (2009) 1.41
Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy. Neuromuscul Disord (2011) 1.36
Guillain-Barré syndrome associated with preceding hepatitis E virus infection. Neurology (2014) 1.33
Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol (2009) 1.16
Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol (2010) 1.16
Neuralgic amyotrophy and hepatitis E virus infection. Neurology (2014) 1.15
TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol (2010) 1.14
Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging (2012) 1.12
Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection. Clin Infect Dis (2008) 1.09
Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy. Muscle Nerve (2013) 1.07
Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. J Neurol Sci (2005) 1.06
Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect Immun (2011) 1.06
Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect (2009) 1.05
Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation? J Neurol Neurosurg Psychiatry (2013) 1.04
Endotoxemia-induced inflammation and the effect on the human brain. Crit Care (2010) 1.02
Omeprazole significantly reduces posaconazole serum trough level. Clin Infect Dis (2009) 0.99
IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins. J Proteome Res (2014) 0.98
Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. Clin Chem (2008) 0.95
Skeletal muscle ultrasound. Neurol Res (2011) 0.94
Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach. Med Mycol (2010) 0.94
Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome. Microbes Infect (2005) 0.94
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. J Neurooncol (2013) 0.93
Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh. PLoS One (2009) 0.92
Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis (2013) 0.92
Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum (2009) 0.91
Progressive muscle atrophy and weakness after treatment by mantle field radiotherapy in Hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys (2011) 0.90
Time-measured phylogenies of gag, pol and env sequence data reveal the direction and time interval of HIV-1 transmission. AIDS (2011) 0.90
BSCL2 mutations in two Dutch families with overlapping Silver syndrome-distal hereditary motor neuropathy. Neuromuscul Disord (2006) 0.89
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients. J Neuroimmunol (2004) 0.88
Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome. J Immunol (2006) 0.87
Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors. Ann Neurol (2003) 0.87
The influence of concentration/meditation on autonomic nervous system activity and the innate immune response: a case study. Psychosom Med (2012) 0.87
PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome. J Clin Microbiol (2007) 0.87
Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS One (2012) 0.87
Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients. Ann Neurol (2003) 0.86
Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial "no use is disuse". Neurorehabil Neural Repair (2013) 0.86
Origin of ganglioside complex antibodies in Guillain-Barré syndrome. J Neuroimmunol (2007) 0.85
Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy. Muscle Nerve (2014) 0.85
Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms. J Neuroimmunol (2005) 0.85
Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice. PLoS One (2012) 0.85
Unusual cluster of HIV type 1 dual infections in Groningen, The Netherlands. AIDS Res Hum Retroviruses (2010) 0.85
Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiol Aging (2009) 0.83
Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α. J Immunol (2013) 0.83
Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study. BMC Pediatr (2010) 0.83
Sural/radial nerve amplitude ratio: reference values in healthy subjects. Muscle Nerve (2005) 0.83
Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands. Antivir Ther (2010) 0.82
Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature. J Neurol (2014) 0.82
Emerging drugs for Guillain-Barré syndrome. Expert Opin Emerg Drugs (2011) 0.82
Long-term outcome of Guillain-Barré syndrome in children. J Peripher Nerv Syst (2014) 0.82
Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates. PLoS One (2011) 0.81
Mortality in Guillain-Barre syndrome. Neurology (2013) 0.81
Detection of antibodies in neuropathy patients by synthetic GM1 mimics. Glycobiology (2011) 0.81
Residual complaints after neuralgic amyotrophy. Arch Phys Med Rehabil (2012) 0.81
Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome. J Peripher Nerv Syst (2009) 0.81
Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology (Oxford) (2009) 0.81
Important issues for perioperative systemic antimicrobial prophylaxis in surgery. Curr Opin Anaesthesiol (2014) 0.81
Atypical dystonic shoulder movements following neuralgic amyotrophy. Mov Disord (2009) 0.81
Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome. J Neuroimmunol (2007) 0.81
Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis. Ann Rheum Dis (2009) 0.80
GM3, GM2 and GM1 mimics designed for biosensing: chemoenzymatic synthesis, target affinities and 900 MHz NMR analysis. Carbohydr Res (2008) 0.80
Active cytomegalovirus infection in patients with acute venous thrombosis: a case-control study. Am J Hematol (2011) 0.80
Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia. Emerg Infect Dis (2007) 0.80
The spectrum of polyneuropathies in childhood detected with electromyography. Pediatr Neurol (2007) 0.80
Return of meningeal symptoms in a patient treated for cryptococcal meningitis. J Neurol (2007) 0.80
Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases. Arthritis Rheumatol (2014) 0.79
Coupling between electroencephalography pattern and cyclic transcranial Doppler flow during aortic root surgery. J Neurosurg Anesthesiol (2011) 0.79
Immunoglobulin gene analysis in polyneuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol (2006) 0.79
Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms. J Neuroimmunol (2008) 0.78
Diaphragmatic weakness caused by neuroborreliosis. Clin Neurol Neurosurg (2010) 0.78
STD-NMR used to elucidate the fine binding specificity of pathogenic anti-ganglioside antibodies directly in patient serum. Biochemistry (2009) 0.78
High incidence of Guillain-Barre syndrome in children, Bangladesh. Emerg Infect Dis (2011) 0.78
Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP. J Peripher Nerv Syst (2011) 0.78
Radiotherapy plus concomitant and adjuvant temozolomide for leptomeningeal pilomyxoid astrocytoma: a case study. J Neurooncol (2006) 0.78
Two donor-related infections in a heart transplant recipient: one common, the other a tropical surprise. J Heart Lung Transplant (2010) 0.78
Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C. Antivir Ther (2011) 0.77
[Imminent respiratory insufficiency in children resulting from Guillain-Barré syndrome]. Ned Tijdschr Geneeskd (2011) 0.77